Hyundai Bioscience Co. Ltd (048410) — Long-term Investment Intensity

Latest as of December 2019: 3.1%

Hyundai Bioscience Co. Ltd (048410) has a Long-term Investment Intensity of 3.1% as of December 2019. Long-term investments of ₩1.97 Billion represent 3.1% of total assets of ₩63.24 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how resilient are Hyundai Bioscience Co. Ltd's assets to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

3.1%
LT Investments / Total Assets

Long-term Investments

₩1.97 Billion
KRW

Total Assets

₩63.24 Billion
KRW

Country

Korea
KQ

Hyundai Bioscience Co. Ltd Long-term Investment Intensity (2014–2019)

This chart shows how Hyundai Bioscience Co. Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 3.1%, reflecting long-term investments of ₩1.97 Billion against total assets of ₩63.24 Billion KRW. For the complete balance sheet picture, see Hyundai Bioscience Co. Ltd total assets.

Annual Long-term Investment Intensity for Hyundai Bioscience Co. Ltd (2014–2019)

The table below presents the year-by-year Long-term Investment Intensity for Hyundai Bioscience Co. Ltd from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read debt load of Hyundai Bioscience Co. Ltd for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2019 3.1% ₩1.97 Billion ₩63.24 Billion ▲ +1.0 pp
2018 2.1% ₩1.16 Billion ₩54.01 Billion ▲ +1.0 pp
2017 1.2% ₩571.51 Million ₩49.50 Billion ▼ -0.3 pp
2016 1.4% ₩773.38 Million ₩53.38 Billion ▲ +0.1 pp
2015 1.4% ₩600.25 Million ₩43.41 Billion ▼ -0.4 pp
2014 1.8% ₩600.25 Million ₩32.81 Billion
pp = percentage points